Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

KEGG DRUG

DrugBank

Drug (Description in trials)

KEGG GENES

KEGG PATHWAY

Disease ID

1

[3] Albuterol; Salbutamol; Ventolin

[1] ADRB2 💬

[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬

[12] 3, 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬

Disease ID	Name
3	Spinal muscular atrophy
11	Myasthenia gravis
12	Congenital myasthenic syndrome
13	Multiple sclerosis/Neuromyelitis optica
49	Systemic lupus erythematosus
85	Idiopathic interstitial pneumonia
86	Pulmonary arterial hypertension
89	Lymphangioleiomyomatosis
111	Congenital myopathy
113	Muscular dystrophy
256	Muscle glycogenosis
299	Cystic fibrosis

2

Amifampridine 💬

[1] Amifampridine

[2] Amifampridine; Firdapse

[4] KCNA4,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNC3	potassium voltage-gated channel subfamily C member 3
KCND2	potassium voltage-gated channel subfamily D member 2
KCND3	potassium voltage-gated channel subfamily D member 3

[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬

[3] 3, 11, 12 💬